Navegar Publicación científica por término MeSH "Acute Coronary Syndrome"

Mostrando ítems 1-6 de 6

Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey

2019- Lane, D. A.; Dagres, N.; Dan, G. A.; García Seara, Javier; Iliodromitis, K.; [et al.]
Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

2019- Steg, P. G.; Szarek, M.; Bhatt, D. L.; Bittner, V. A.; Bregeault, M. F.; [et al.]
Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome

2013- Raposeiras Roubín, Sergio; Rodiño Janeiro, Bruno K; Paradela Dobarro, Beatriz; Grigorian Shamagian, Lilian; García Acuña, José María; [et al.]
Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome

2019- Baluja González, María Aurora; Rodríguez Mañero, Moises; Cordero, A.; Kreidieh, B.; IGLESIAS ALVAREZ, DIEGO; [et al.]
Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome

2020- Baluja, A.; Rodríguez-Mañero, M.; Cordero, A.; Kreidieh, B.; Iglesias-Alvarez, D.; [et al.]
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

2019- Roe, M. T.; Li, Q. H.; Bhatt, D. L.; Bittner, V. A.; Diaz, R.; [et al.]